And the Novavax Covid-19 vaccine that just got emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) is certainly new. It’s new in that it’s not completely new.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

LONDON -- American biotechnology company Novavax announced Monday that its experimental COVID-19 vaccine was more than 90% effective against symptomatic disease in late-stage clinical trials ...

Earlier this month, the U.S. Department of Health and Human Services (HHS) announced that the Biden administration had secured 3.2 million doses of Novavax’s COVID-19 vaccine, which will be made ...

Dr. Nita Patel, Director of Antibody discovery and Vaccine development, lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020 ...

Novavax Inc. said Thursday Jan. 28, 2021 that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well ...

COVID-19 death toll nears 600,000 in U.S. 02:28 Vaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in ...

The FDA authorized an updated version of the protein-based Novavax COVID-19 vaccine for use in people 12 and up. Doses could be available by next week.

Novavax is moving closer to being approved in the U.S. as the newest inoculation against COVID-19, raising hopes that its more established technology will win over vaccine skeptics and increase ...

Novavax is new in the covid-fighting arsenal, but it uses the same technology as more established vaccines. Here's how it differs from Pfizer, Moderna and Johnson & Johnson.

The U.S. Food and Drug Administration on Friday authorized an updated version of the protein-based Novavax COVID-19 vaccine for use in people 12 and up. Doses could be available by the end of next ...